CI

At a glance

ClinicalIndex Comparison Record
N/ASuspended· 30 target
Drug / intervention
Electroencephalography +1 moreprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05091632
NCT05091632N/ASuspended
Suspended
CompareCT.gov

Can You Hear Me? Assessment of Verbal Comprehension and Cognitive Processes in Patients in the Last Days of Life

M.D. Anderson Cancer Center·observational·Posted Oct 25, 2021·Updated Apr 15, 2026

In Brief

An observational study evaluating Electroencephalography and Questionnaire Administration for Hematopoietic and Lymphoid Cell Neoplasm and 3 related conditions. Suspended, targeting 30 participants across 1 site.

Signals

Trial is currently suspended

Detailed Summary

This study investigates the use electroencephalography (EEG - a test that measures brain waves) to learn if patients who appear unresponsive (do not respond to noises, words, or touch) retain any consciousness. Families want to know if their loved ones who are unresponsive can still hear them or feel any discomfort. Information gained from this study may have important impact in how patients, caregivers, and doctors make decisions.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsHematopoietic and Lymphoid Cell Neoplasm, Locally Advanced Malignant Solid Neoplasm, Metastatic Malignant Solid Neoplasm, Recurrent Malignant Solid Neoplasm
CountriesUnited States
Collaborators--

Timeline

N/ASuspended
202220232024202520262027
First PostedOct 25, 2021
Enrollment StartMay 4, 2021
Primary CompletionFeb 2, 2027
TodayJul 1, 2026
Enrollment to primary: 5.7 yearsPosted 4.7 years agoPrimary completion in 7 months

Interventions

Electroencephalographyprocedure

Undergo EEG

Questionnaire Administrationother

Complete questionnaires